A detailed history of Financial Enhancement Group LLC transactions in First Trust Nyse Arca Biotechn stock. As of the latest transaction made, Financial Enhancement Group LLC holds 4,886 shares of FBT stock, worth $876,304. This represents 0.15% of its overall portfolio holdings.

Number of Shares
4,886
Previous 3,697 32.16%
Holding current value
$876,304
Previous $635,000 27.87%
% of portfolio
0.15%
Previous 0.11%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 14, 2025

BUY
$161.65 - $178.69 $192,201 - $212,462
1,189 Added 32.16%
4,886 $812,000
Q3 2024

Oct 31, 2024

SELL
$152.39 - $172.91 $186,982 - $212,160
-1,227 Reduced 24.92%
3,697 $635,000
Q2 2024

Aug 02, 2024

BUY
$141.52 - $156.4 $3,679 - $4,066
26 Added 0.53%
4,924 $758,000
Q1 2024

Apr 15, 2024

BUY
$145.08 - $160.46 $23,648 - $26,154
163 Added 3.44%
4,898 $753,000
Q4 2023

Jan 18, 2024

BUY
$132.5 - $158.45 $100,037 - $119,629
755 Added 18.97%
4,735 $748,000
Q3 2023

Oct 17, 2023

BUY
$145.69 - $157.89 $10,052 - $10,894
69 Added 1.76%
3,980 $582,000
Q2 2023

Aug 10, 2023

BUY
$151.19 - $159.79 $32,354 - $34,195
214 Added 5.79%
3,911 $598,000
Q1 2023

May 17, 2023

SELL
$147.92 - $165.37 $5,916 - $6,614
-40 Reduced 1.07%
3,697 $573,000
Q4 2022

Feb 09, 2023

SELL
$132.87 - $159.04 $3,056 - $3,657
-23 Reduced 0.61%
3,737 $575,000
Q3 2022

Oct 27, 2022

BUY
$128.6 - $149.75 $18,904 - $22,013
147 Added 4.07%
3,760 $496,000
Q2 2022

Aug 09, 2022

BUY
$123.32 - $155.54 $215,193 - $271,417
1,745 Added 93.42%
3,613 $490,000
Q1 2022

May 18, 2022

BUY
$137.27 - $163.07 $6,863 - $8,153
50 Added 2.75%
1,868 $279,000
Q4 2021

Jan 28, 2022

BUY
$153.09 - $169.84 $28,627 - $31,760
187 Added 11.47%
1,818 $294,000
Q3 2021

Oct 14, 2021

BUY
$164.82 - $176.04 $28,349 - $30,278
172 Added 11.79%
1,631 $271,000
Q2 2021

Aug 10, 2021

BUY
$157.67 - $176.2 $18,447 - $20,615
117 Added 8.72%
1,459 $252,000
Q1 2021

May 10, 2021

BUY
$156.06 - $184.84 $1,092 - $1,293
7 Added 0.52%
1,342 $215,000
Q4 2020

Feb 10, 2021

BUY
$152.75 - $174.52 $305 - $349
2 Added 0.15%
1,335 $224,000
Q3 2020

Nov 18, 2020

SELL
$150.39 - $180.07 $3,007 - $3,601
-20 Reduced 1.48%
1,333 $210,000
Q2 2020

Aug 14, 2020

BUY
$127.11 - $171.8 $2,287 - $3,092
18 Added 1.35%
1,353 $227,000
Q1 2020

May 04, 2020

BUY
$114.56 - $156.02 $150,417 - $204,854
1,313 Added 5968.18%
1,335 $175,000
Q4 2019

Jan 31, 2020

SELL
$120.34 - $154.01 $3,369 - $4,312
-28 Reduced 56.0%
22 $3,000
Q3 2019

Nov 08, 2019

SELL
$123.44 - $131.99 $4.01 Million - $4.29 Million
-32,480 Reduced 99.85%
50 $6,000
Q2 2019

Aug 06, 2019

BUY
N/A
7,870 Added 31.91%
32,530 $4.58 Million
Q1 2019

May 14, 2019

SELL
N/A
-18,873 Reduced 43.35%
24,660 $3.72 Million
Q4 2018

Jan 08, 2019

BUY
N/A
37 Added 0.09%
43,533 $6.9 Million
Q3 2018

Nov 19, 2018

BUY
N/A
2,096 Added 5.06%
43,496 $6.89 Million
Q2 2018

Aug 08, 2018

BUY
N/A
41,400 New
41,400 $5.8 Million

Others Institutions Holding FBT

About FIRST TRUST NYSE ARCA BIOTECHN


  • Ticker FBT
  • Sector ETFs
  • Industry ETFs
More about FBT
Track This Portfolio

Track Financial Enhancement Group LLC Portfolio

Follow Financial Enhancement Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Enhancement Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Financial Enhancement Group LLC with notifications on news.